SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021)

Other authors

Institut Català de la Salut

[Fernández-Montes A] Medical Oncology Department, Complexo Hospitalario Universitario de Ourense, Ourense, Spain. [Alcaide J] Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain. [Alsina M] Medical Oncology Department, Hospital Universitario de Navarra (HUN), Pamplona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Custodio AB] Medical Oncology Department, Hospital Universitario la Paz, CIBERONC Madrid, Spain. [Franco LF] Medical Oncology Department, Hospital Virgen de la Salud, Toledo, Spain. [Gallego Plazas J] Medical Oncology Department, Hospital General Universitario de Elche, Elche, Alicante, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2022-08-12T06:31:17Z

2022-08-12T06:31:17Z

2022-04



Abstract

Diagnosis; Esophageal cancer; Treatment


Diagnóstico; Cáncer de esófago; Tratamiento


Diagnòstic; Càncer d'esòfag; Tractament


Esophageal cancer is an aggressive tumor, and is the sixth-leading cause of death from cancer. Incidence is rising in Spain, particularly among men. Two main pathological different subtypes have been described: squamous cell carcinoma and adenocarcinoma. Growing evidence of their epidemiology and molecular differences explains their different response to novel treatments, and they are therefore likely to be treated as two separate entities in the near future. The best results are obtained with a multidisciplinary therapeutic strategy, and the introduction of immunotherapy is a promising new approach that will improve prognosis. In these guidelines, we review the evidence for the different methods of diagnosis and therapeutic strategies that form the basis of our standard of care.

Document Type

Article


Published version

Language

English

Publisher

Springer

Related items

Clinical and Translational Oncology;24

https://doi.org/10.1007/s12094-022-02801-2

Recommended citation

This citation was generated automatically.

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)